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Abstract
Quantifying the degree of atrophy is done clinically by neuroradiologists following established
visual rating scales. For these assessments to be reliable the rater requires substantial training
and experience, and even then the rating agreement between two radiologists is not perfect. We
have developed a model we call AVRA (Automatic Visual Ratings of Atrophy) based on machine
learning methods and trained on 2350 visual ratings made by an experienced neuroradiologist.
It provides fast and automatic ratings for Scheltens’ scale of medial temporal atrophy (MTA),
the frontal subscale of Pasquier’s Global Cortical Atrophy (GCA-F) scale, and Koedam’s scale
of Posterior Atrophy (PA). We demonstrate substantial inter-rater agreement between AVRA’s
and a neuroradiologist ratings with Cohen’s weighted kappa values of κw = 0.74/0.72 (MTA
left/right), κw = 0.62 (GCA-F) and κw = 0.74 (PA), with an inherent intra-rater agreement of
κw = 1. We conclude that automatic visual ratings of atrophy can potentially have great clinical
and scientific value, and aim to present AVRA as a freely available toolbox.
1. Introduction
The assessment of structural changes in the brain is made clinically by visual ratings of brain
atrophy according to established visual rating scales. They offer an efficient and inexpensive
method of quantifying the degree of atrophy and can help to improve the specificity and sensi-
tivity of dementia diagnoses [1, 2]. However, there are limitations associated with visual ratings
of atrophy, which may explain why they are still not widely used in the clinical routine. First,
the ratings are inherently subjective which means that the agreement between two radiologist
might be low if they have not had sufficient training [1]. Second, in order to achieve adequate
reliability the radiologist needs to be experienced and regularly perform ratings for the repro-
ducibility not to drop [3]. Third, the ratings are relatively time consuming and tedious. It takes
a few minutes per image [4], depending on rating scale and level of rating experience. While
this amount of time may be feasible in most clinical settings, it does not easily allow studying
large imaging cohorts of potentially thousands of images. An automatic method would remove
the inter- and intra-rater variability and eliminate the time-consuming process of rating.
1.1. Visual rating scales
Amongst the most commonly used rating scales—both in research and in clinical routine—are
Scheltens’ Medial Temporal Atrophy (MTA) scale [5], Koedam’s scale for Posterior Atrophy (PA)
I
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1.1 Visual rating scales 1 INTRODUCTION
MTA 0 1 2 3 4
GCA-F 0 1 2 3
PA 0 1 2 3
Figure 1: Examples of Scheltens’ MTA scale [5], Pasquier’s frontal subscale of GCA [8], and Koedam’s PA scale
[6]. The MTA ratings are done in the coronal plane, GCA-f in the axial plane, and PA ratings are based on
assessments of all three planes. The area between the dashed lines in the left images indicates the slices assessed
by a radiologist for the GCA-F and PA scales, while it shows the single slice assessed for MTA. The red boxes
show the regions assessed for each rating scale.
[6] and Pasquier’s scale for Global Cortical Atrophy (GCA) [7, 8] (see Fig. 1 for examples). These
scales have previously been validated by quantitative neuroimaging techniques [9, 10, 11, 12].
The MTA scale was developed by Scheltens et al. (1992) [5]. A rating is given for each
hemisphere ranging from 0 (no atrophy) to 4 (severe atrophy) and focuses on three structures: the
width of the choroid fissure, the width of the temporal horn and the height of the hippocampus.
The assessment is made in a single or few coronal slices on a high quality CT or ideally a T1-
weighted MRI. Different cut-offs have been suggested where the most common is that an average
MTA score ≥ 2 is considered pathological if the patient is younger than 75 years old, and an
average MTA ≥ 3 for patients older than 75 years [5, 13, 14].
The PA scale assesses atrophy of the parietal lobe of the brain and was proposed by Koedam
et al. (2011) [6]. A rating from 0 (no atrophy) to 3 (severe atrophy) is given that specifically
assesses the degree of atrophy of the precuneus, the posterior cingulate sulcus, the parieto-
occipital sulcus and the parietal cortex.
Pasquier et al. (1996) developed a visual rating system of cerebral atrophy in 13 different
brain regions that assesses the level of dilatation of sulci and the ventricles [8]. For each of these
regions a score ranging from 0 (no atrophy) to 3 (severe atrophy) is given by the radiologist.
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These measures have been simplified into a global assessment of cortical atrophy rated from 0 to 3
called the GCA scale. The original paper by Pasquier and colleagues used T2-weighed images[8]
but several studies have also assessed GCA in T1-weighted images [13, 12, 15, 7]. A frontal
subscale of GCA (GCA-F) is of particular interest since frontal atrophy has been shown to be
associated with executive dysfunction [16] and can offer improved diagnosis of frontotemporal
dementia (FTD) [12].
1.2. Related work
A few automatic (or semi-automatic) methods to quantify medial temporal atrophy—besides
volumetrics—have previously been proposed. Two of them involve planimetrics based on manual
delineation of hippocampus and surrounding structures that are combined into a single score of
medial temporal atrophy [17, 18]. While these methods assess almost the same structures as
Scheltens’ MTA scale, the different scales are not interchangeable and do not necessarily reflect
the same atrophy patterns. Another study recently reported an automatic method that is trained
on radiologist ratings which predicts MTA scores based on volumetric measures extracted from
the MRI image [19]. Volumetric measures of brain regions can not be extracted from most CT
images nor do they retain any information regarding the shape of the structures. It is reasonable
to assume that the shapes are important since the visual MTA rating is done on a single slice,
from which it is not possible to estimate the hippocampal volume.
Deep learning—a branch of machine learning—has recently generated impressive results in
several fields, such as speech recognition, text semantics, image recognition and genomics [20].
Convolutional neural networks (CNN’s) have already been substantially applied in medical image
analysis (for recent reviews, see [21, 22]). For instance, studies using CNN’s have achieved
similar levels of accuracy as medical experts in classifying skin cancer [23], mammographic
skin lesion detection [24], and diabetic retinopathy diagnosis [25]. Focusing on applications in
neuroimaging, deep neural networks have been used successfully for automatic methods of skull
stripping [26, 27], brain age prediction [28], brain segmentation [29], PET image enhancement
[30] and brain tumor segmentation [31, 32] to name a few. In dementia research, several studies
have investigated brains of patients with Alzheimer’s disease (AD) using deep learning and shown
impressive diagnostic abilities [33, 34, 35, 36]. A Recurrent Neural Network (RNN) is an artificial
neural network that has an internal state (or ”memory”) and is useful when processing sequential
data, such as words in a sentence or frames in a video[20, 37]. RNN’s have successfully been
combined with CNN’s to segment MRI images, where the addition of an RNN module helped to
leverage adjacent slice dependencies [38, 39].
1.3. Our approach
In this study, we aimed to develop an automatic algorithm based on convolutional and re-
current neural networks that provides fast, reliable, and systematic predictions of established
visual ratings scales of atrophy of brain regions often affected in dementia: the MTA, GCA-F
and PA scales. The models are trained on a large set of MRI images that have been rated by
an experienced neuroradiologist. This method is atlas-free and requires minimum amount of
setup and third-party software. We plan to present the proposed algorithm as a freely available
software targeted towards neuroimaging researchers.
2. Material and methods
2.1. MRI data and protocols
Two different dementia cohorts of MRI images were included in this project: Alzheimer’s
Disease Neuroimaging Initiative (ADNI) and a clinical cohort with images from the memory
clinic at Karolinska University Hospital (referred to as MemClin from here on). Informed consent
was obtained for all participants, or by an authorized representative of theirs.
Individuals in the MemClin cohort mainly consisted of patients clinically diagnosed with
dementia according to the ICD-10 criteria between 2003 and 2011. All participants underwent
a T1-weighted MRI scan at the Radiology Department of Karolinska University Hospital in
Stockholm, Sweden. Exclusion criteria were if the patient had other types of dementia, history
of traumatic brain injury, or insufficient quality of the MRI scan [40, 41].
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Table 1: The rating distribution of the images used in the study. The ”Images” column refers to how many
unique images that were rated by the radiologist at least once. Both the left and right MTA ratings are presented
in the ”MTA” column in the Table.
Cohort Images
MTA GCA-F PA
0 1 2 3 4 0 1 2 3 0 1 2 3
ADNI 1966 425 1581 1147 555 224 1449 468 49 0 1188 611 157 10
MemClin 384 23 265 296 139 45 279 89 14 2 210 127 43 4
Total 2350 448 1846 1443 694 269 1728 557 63 2 1398 738 200 14
Data used in the preparation of this article were obtained from the Alzheimer’s Disease Neu-
roimaging Initiative (ADNI) database (adni.loni.usc.edu). The ADNI was launched in 2003
as a public-private partnership, led by Principal Investigator Michael W. Weiner, MD. The pri-
mary goal of ADNI has been to test whether serial magnetic resonance imaging (MRI), positron
emission tomography (PET), other biological markers, and clinical and neuropsychological as-
sessment can be combined to measure the progression of mild cognitive impairment (MCI) and
early Alzheimer’s disease (AD). For up-to-date information, see www.adni-info.org. A major-
ity of the participants in the ADNI cohort were scanned multiple times within a few weeks—often
in the same day. A subset of participants were scanned both in 1.5T and 3T machines.
All available images with an associated visual atrophy rating performed by a neuroradiologist
were used in this study. Images that did not pass the initial automatic AC/PC-alignment (the
anterior and posterior commissures) were excluded from the training and evaluation process (144
out of 5355 images in total).
The algorithm was developed using theHiveDB database system[42] and will become part of
its automated activity system.
2.2. Human ratings
An experienced neuroradiologist, Lena Cavallin (L.C.), visually rated 2350 T1-weighted MRI
images over the course of 16 months with no prior knowledge of age, sex, or diagnosis. For
ADNI subjects scanned more than once, only one of the images was rated by the radiologist and
the additional image(s) were labeled with the same rating. The distribution of L.C.’s MTA, PA
and GCA-F ratings are shown in Table 1. Many of the ADNI ratings have been analyzed and
reported in previous studies [40, 13, 12, 15, 14]. All visual ratings of MTA, PA and GCA-F were
based on T1-weighted MRI images, and illustrative examples of the ratings can be seen in Fig.
1. The images were aligned with AC/PC by the radiologist if the protocol allowed for it [3].
The MTA ratings were made in a single coronal slice, just behind the amygdala and mammillary
bodies. The GCA-F ratings were based on multiple sagittal slices, whereas the PA score was
based on slices in all three planes.
2.3. Computer ratings
The motivation behind the proposed model architecture was to mimic how a neuroradiol-
ogist would process an MRI image: to scroll through the brain volume slice-by-slice looking
for the ”correct” slice(s) to base the rating on. A human rater assesses images acquired using
different scanners, vendors and protocols without any need for substantial preprocessing such
as segmentation, intensity normalization, non-linear registrations or skull-stripping. To better
mimic the clinical situation (and to keep the number of time consuming preprocessing steps that
can potentially fail to a minimum) we trained AVRA to rate images with as little preprocessing
as possible. The main difference between AVRA’s and a human rater is that AVRA’s ratings
are continuous instead of discrete.
All code in this project was developed in Python 3.4.3 using the deep learning framework
PyTorch 1.0 [43].
Preprocessing
The only preprocessing included in our method is the registration of all brains to the MNI
standard brain using FSL FLIRT 6.0 (FMRIB’s Linear Image Registration Tool) [44, 45, 46].
This rigid transform is computed with 6 degrees of freedom (i.e. rotation and translation only)
and is used to automatically AC-PC align each brain and conform all images to the same voxel
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Figure 2: A sketch of the architecture of AVRA, with the example of a GCA-F prediction. The MTA and PA
models followed the same structure.
size (1x1x1mm3) and input dimension (182x218x182). The AC-PC aligned images are cropped
to remove excess space outside the brain and redundant slices not part of the ratings scale (as
indicated in Figs. 1 and 2). The center-voxel of the cropped images depended on the rating
scale. For the MTA ratings, 22 coronal slices of the dimension 128mm x 128mm are input to the
model—enough to ensure that the ”correct” rating slice is included. The GCA-F ratings are done
on multiple axial slices so each volume is cropped to 160mm x 192mm x 40 slices, with 2mm slice
thickness. The PA model requires slices from all three anatomical planes. From each MRI image
a smaller volume of 128mm x 128mm x 128mm was extracted from the parietal lobe, sufficiently
large to include all relevant structures in the parietal cortex. From this cropped volume 37 axial,
28 coronal and 34 sagittal slices with 2mm slice thickness (i.e. 99 slices in total) were used as
input to the model. Since the distribution of raw voxel values was very different—particularly
between 1.5T and 3T images—all cropped volumetric images were normalized to have a zero
variance and mean.
Model architectures
The overall structure of the models can be seen in Fig. 2 and can be split into three parts.
First, relevant features from a single slice are extracted using a Residual Attention Network [47],
detailed in Fig. 3. It combines the abilities from residual learning [48], which can allow for even
deeper models, and attention models that can ”focus” spatially on images—particularly useful
for visual ratings since they are based on regional atrophy [49, 50]. Our implementation is a
slimmed version of the original, with the same depth but a smaller number of filters in each
layer to reduce memory usage and computation time. Initial experiments showed no noticeable
performance reduction on the validation set compared to using a larger network. Second, the
features are reshaped to a 1D vector and fed to an RNN, which consists of a two-layer Long-
Short Term Memory (LSTM) network with 256 hidden nodes [51, 52]. The LSTM modules are
expected to ”remember” relevant features seen in previous slices and update its state (”memory”)
when it is exposed to a slice containing useful information for the rating. Finally, when slice 0, 1,
..., (n− 1) have been propagated through the network, the final output from the second LSTM
module h
(2)
n is used to make a linear prediction of the visual rating. All three models share the
same network architecture except for the size of the input vector fed to the LSTM network, as
5
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Figure 3: A sketch of the residual attention net used to extract features from individual MRI slices, where the
flattened output is fed to the RNN. The downsampling block consists of stacking maxpooling operations followed
by a residual block. The upsamling is performed with bilinear interpolations of the output of a residual block.
The ”+”, ”x”, and ”S-shaped” symbols denote element-wise summation, multiplication and the sigmoid function,
respectively. The flow chart is adapted from [47].
that is dependent on the input size of the MRI slices.
For comparison, we train a VGG16 network [53] without the RNN part, where the 3D volumes
are treated as multi-channel 2D images. That is, for the MTA model we input one ”22-channel”
image to the CNN once instead of 22 single-slice images.
Training
For training and evaluation, the dataset was randomly split into a training and a hold-out
test set, where 20% of all subjects where assigned to the test set. On the remaining images in
the training set we applied 5-fold cross validation for hyper-parameter tuning for each rating
scale. The five trained models were used together as an ensemble classifier evaluated on the test
set, where the average prediction was considered the final rating.
The models were trained for 200 epochs using backpropagation and optimized through
stochastic gradient descent (SGD) with cyclic learning rate to maximize the probability of pre-
dicting the radiologist’s rating [54, 55]. The training set was randomly split into minibatches,
each containing 20 MRI images, and the weights were updated to minimize the mean-squared
error between the automatic and the integer ratings by L.C. We employed data augmentation
in the training process of the network to reduce the risk of overfitting to the training set. This
included random cropping (within ±10mm off the center voxel), scaling, left/right mirroring, and
randomly selecting N4ITK inhomogeniety corrected images instead of the original file [56]. Due
to the imbalance of ratings in the dataset we employed random oversampling of images with less
frequent ratings, which has been shown to improve the prediction performance of CNN’s [57].
For ADNI subjects that had multiple scans for a single timepoint, a scan was selected randomly
for each minibatch.
2.4. Analyses metrics
The visual rating scales are subjective measures by definition. Consequently, there are no
objective ground truth ratings available. In most studies, the performance of a rater is reported
in kappa statistics—a group of measures that can quantify the level of agreement between two
sets of discrete ratings—but there is no single metric always reported. To make our results
comparable to previous findings, we present our results with Cohen’s weighted kappa (κw), which
has been used in several previous rating studies [6, 14, 3, 58, 12, 15, 59], as well as accuracy and
the Pearson correlation coefficient (ρ). The agreement between two sets of ratings is referred to
inter -rater agreement if the sets were assessed by different raters, and intra-rater agreement if
a single radiologist rated the set twice.
3. Results
3.1. Intra-rater agreements
To have an idea of the variability in the human ratings used for training in this project, we
studied the intra-rater agreement in a subset of 244 images that had been rated 2-4 times with
at most 16 months from the first to the last rating session. To be consistent with the computer
training and evaluation procedure, we compared the latest rating to a previous one. If there were
more than two ratings, the previous rating was chosen randomly. This yielded κw agreements
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Table 2: Previously reported intra- and inter-rater agreements together with the test set agreement between
L.C. and AVRA, and L.C and VGG16 as a reference. The interval given refers to the minimum and maximum
weighted kappa (κw) value reported in the referenced study.
Study Scale N
Intra-rater
agreement (κw)
Inter-rater
agreement (κw)
Cavallin et al. (2012) [3] MTA 100 0.83-0.94 0.72 - 0.84
Cavallin et al. (2012b) [58] MTA 100 0.84-0.85 —
Westman et al. (2011) [14] MTA 100 0.93 —
Velickaite et al. (2017) [59] MTA 390 0.79-0.84 0.6-0.65
Ferreira et al. (2017) [15] MTA 120 0.89-0.94 0.70-0.71
Koedam et al. (2016) [6] MTA 29-118 0.91-0.95 0.82-0.90
VGG16 MTA 464 1 0.58 - 0.59
AVRA MTA 464 1 0.72 - 0.74
Koedam et al. (2016) [6] PA 29-118 0.93-0.95 0.65-0.84
Ferreira et al. (2017) [15] PA 120 0.88 0.88
VGG16 PA 464 1 0.63
AVRA PA 464 1 0.74
Ferreira et al. (2016) [12] GCA-F 100 0.70 0.59
Ferreira et al. (2017) [15] GCA-F 120 0.83 0.79
VGG16 GCA-F 464 1 0.56
AVRA GCA-f 464 1 0.62
and accuracies for MTA (left): κw = 0.83, acc = 76%; MTA (right): κw = 0.79, acc = 70%;
GCA-F: κw = 0.46, acc = 71%; PA κw = 0.65, acc = 72%. Ratings made only 1 week apart
showed substantially better intra-rater agreement (see Ferreira et al. (2017) entry in Table 2).
These results provide an estimate of the ”human-level agreement”—i.e. approximate levels of
agreement our models should be able to achieve by training on the available cohort due to rating
inconsistencies over 16 months.
Since there are no random elements in the evaluation process of a brain image, the ”intra-
rater” agreement of AVRA is inherently κw = 1.
3.2. Inter-rater agreements
Our models predicted continuous rating scores of an image, based on training from discrete
ratings by L.C. We rounded AVRA’s ratings to the nearest integer to be able to compare the
rating consensus in terms of accuracy and kappa statistics. The agreements between the ra-
diologist’s and AVRA’s (as well as the VGG networks’) ratings on the hold-out test set are
summarized in Table 2 together with previously reported κw values of inter- and intra-rater
agreements. The inter-rater agreement kw, Pearson correlation ρ, and accuracy on the test set
for MTA (left): κw = 0.74, acc = 70 %; MTA (right): κw = 0.72, ρ = 0.88, acc = 70 %; GCA-F:
κw = 0.62, ρ = 0.71, acc = 84 %; PA: κw = 0.74, ρ = 0.85, acc = 83%. These agreement levels
were similar to previously reported in studies, see Table 2. The naive VGG16 implementations
showed lower inter-rater agreements with the radiologist compared to AVRA.
To increase interpretability and understanding of the models, we computed gradient-based
sensitivity maps of images in the test set based on the SmoothGrad method [60]. These indicated
how influential individual voxels were in the rating prediction, which we can apply to verify that
the network identified the correct features. Examples of AVRA’s rating predictions for each scale
are shown in Fig. 4. As can be observed, the MTA sensitivity maps were generally focused only
around the area of the hippocampus and the inferior lateral ventricle in ∼ ± 3 slices from the
”correct” rating slice. The sensitivity maps in other more posterior and anterior slices were close
to zero. The GCA-F maps were more diffused, but the greatest magnitudes were primarily seen
in the sulci of the frontal lobe. The PA maps were mainly visible in the parietal lobe and in the
sagittal plane, with the greatest magnitudes appearing in parieto-occiptal sulcus and precuneus.
4. Discussion
We have developed a tool for automatic visual ratings of atrophy (AVRA) that is fast, sys-
tematic and robust. AVRA is trained on a large set of images rated by an expert neuroradiologist
using the established clinical assessment measures of Scheltens’ MTA scale, Pasquier’s GCA-F
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MTA GCA-F PA
Figure 4: Examples of sensitivity maps for the MTA, GCA-F and PA scale, respectively. These maps indicate the
influence each voxel had in AVRA’s rating. The particular slices displayed were chosen manually as representative
images for each rating scale.
scale and Koedam’s PA scale with agreement levels similar to that between two experienced
radiologists. This tool runs in under 1 minute on a regular laptop, which enables automatically
rating thousands of images in a couple of hours. Rating an MRI image of the brain requires
minimum amount of preprocessing and the models were built to potentially work in a clinical
setting. The main advantage of an automatic model is the absence of randomness, which can
ensure rating consistency between different clinics, research groups and cohorts. Thus, AVRA
has potential to function as a clinical aid, and to increase the use of visual ratings in research.
4.1. Agreement levels
The rating agreements between AVRA’s and the radiologist’s ratings were considered sub-
stantial (i.e. between 0.6-0.8) according to the often cited paper by Landis and Koch (1977) [61].
The agreements were close to the ”human-level agreements” in this study (i.e. the agreement
between the multiple L.C. ratings of the same image). This was reasonable since a model trained
on imperfect labels due to rating inconsistency can never achieve perfect agreement. A previous
study has investigated the overtime reliability of MTA ratings, where their results showed that
the intra-rater agreement is typically higher when a set is rated twice closer in time–especially
when the radiologist do not rate images on a daily basis [3]. The time between ratings is often not
reported, but in Pasquier’s introduction of the GCA scale the second rating was performed 24 h
after the first [8]. Thus it is reasonable that if all images in a study were rated twice 16 months
apart, the intra-rater agreement would generally be lower than the actual reported values. Our
analysis of the subset of images rated more than once suggests this to be the case. Those values
may not necessarily reflect the ”true” rating consistency either since the multiple-rating subset
does not follow the same distribution as the whole cohort. Limiting the time span between the
first and last set of ratings meant having to discard a large part of the images in the training
set, and initial investigations of this showed decreasing agreement in our study. This suggested
that a large number of images for training was more important than the potential inclusion of
noisy labels.
AVRA’s ratings agreed more with the radiologist ratings than the VGG16 models’ did. A
recurrent CNN architecture might thus be particularly suitable for visual rating predictions, but
we can not say from these results if it were the residual modules, the attention components,
or the LSTM cells—all used in AVRA but not in the VGG16 models—that had the greatest
positive impact on the performance. Another contributing factor may be the wide difference
in the number of trainable parameters between AVRA (1.5M) and VGG16 (65M) that makes
AVRA less prone to overfit on the training data. However, it should be noted that we spent more
time to tune and optimize AVRA compared to the VGG16 networks, which biases the results in
favor of AVRA.
The automatic model presented by Lo¨tjo¨nen and colleagues (2017) is, to our knowledge, the
only software that also attempts to predict scores based on clinical visual rating scales [19]. It is
based on volume measures of hippocampus and surrounding structures, whereas AVRA predicts
the ratings directly from the voxel intensity values. This makes our proposed method promising
to also work on MRI images with large slice thickness and CT images, from which volumes
generally cannot be computed. The fact that CT is a cheaper and more commonly used imaging
8
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Figure 5: Comparison between AVRA’s continuous ratings and the neuroradiologist’s discrete ratings of the
same images. Rows: MRI slices with MTA on the right side of the image (side indicated by the red squares)
rating of 2 (top) and 3 (bottom) given by neuroradiologist. Columns: corresponding continuous AVRA ratings.
E.g., the second image from the left in the bottom row was given assessed to have a left MTA score of 3 by the
neuroradiologist and 2.2 by AVRA. When the radiologist re-examined these cases the same ratings were given
for all images, except for the three images on the right in the top row (Radiologist: 2, AVRA: 2.6, 2.8 and 3.0),
which were instead given MTA scores of 3. The image rated 2 by L.C. and 2.4 by AVRA was described as a
subject between 2 and 3.
modality than MRI in the clinics speaks in favor of using convolutional neural networks over
volumetrics for automatic ratings of atrophy [62]. No κw values are reported in [19], but they
provided correlation coefficients between radiologist and computer ratings for the MTA scale as
0.86 (left) and 0.85 (right). AVRA showed a similar magnitude of correlation for the MTA scale
on the hold-out test set: ρ = 0.88.
4.2. Reliability of AVRA
One of the main motivations of having a computer rate brain atrophy instead of humans
is its inherent perfect intra-rater agreement—the same image will be rated exactly the same
regardless of when (and where) it is rated. A relevant question to ask is: why not let a computer
segment and calculate e.g. hippocampal volumes instead of an MTA rating? We see three main
motivations for this: 1) CT, and some MRI protocols, have too large slice thickness that do not
allow for extracting reliable volumetric information from the images. 2) Segmentaion methods
will—just as AVRA—fail in processing some cases, and for clinician to manually intervene and
delineate structures would neither be feasible nor practical. If an automatic visual rating would
fail the radiologist would be able to quickly perform their own visual rating, as is done today.
3) There is a lack of how to clinically interpret volumetric data, e.g. the hippocampal volumes.
However, extensive research has been done on cut-offs for visual rating scales, even considering
modulating factors such as age [13].
The sensitivity maps shown in Fig. 4 suggested that the models were able to correctly
identify relevant structures to base their ratings on. Particularly the sensitivity maps of the
MTA model were typically not visible ±3mm from the ”correct” rating slice, indicating that
the employed recurrent CNN architecture used was able to correctly identify relevant slices
and disregard redundant ones. The diffused sensitivity maps seen for the GCA-F scale was also
observed in the quantitative validation study done by Ferreira et al. (2015), showing that frontal
atrophy is also associated with temporal and posterior atrophy—at least in the ADNI cohort
[12]. Mo¨ller and colleagues (2014) found, using VBM analysis, significant differences between PA
ratings not only in the parietal lobe, but also in parts of the cerebellum, temporal lobe and the
occipital lobe [11]. Their study was also performed on a cohort with individuals with probable
AD and subjective memory complaints, concluding that atrophy solely in the posterior cortex
is an exception. The sensitivity maps from our PA model indicate that AVRA based the PA
ratings on mainly the same regions. AVRA learns to how to predict a GCA-F or a PA score from
an MRI image only based on previous human ratings. Thus, if e.g. frontal atrophy is strongly
associated with atrophy in the temporal lobe, the model is likely to find it difficult to learn to
only assess the frontal lobe in the GCA-F scale. Since the sensitivity maps are based on the
absolute values of the calculated gradients in the backward propagation, the magnitude of these
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Figure 6: Box plots of the difference between AVRA’s continuous and the radiologist’s discrete ratings of the
same image (stratified by radiologist score) for the MTA (red), GCA-F (green), and the PA scale (blue). There
were no images assigned a rating of GCA-F=3 by the radiologist and only 1 image with PA=3 in the test set,
which explains the absence of boxes for these ratings.
decrease every time it propagates through the LSTM cell due to the point-wise multiplication in
the forget gate [52]. The PA model inputs 99 slices. As the sagittal slices are the last to be fed
to the model it is reasonable to assume that they dominate the sensitivity maps as opposed to
early axial slices, which have propagated through the LSTM cell almost 100 times.
The performance of AVRA was validated in a test set that was randomly sampled from the
same cohorts as the training data set. This means that the data distribution in the test set was
similar to the image samples that the models were trained on. This is a simpler test set than if
the test set was from a different cohort with images acquired using other scanning parameters.
We are currently in the process of validating how the models would handle data from a different
image distribution (cohort), and the effect it would have on the rating agreement.
Frequently, it is difficult for a radiologist to decide between two scores, and in a clinical
situation the level of atrophy is often described as ”the left MTA is between 2 and 3” for
instance. This nuance might be important information for the physician diagnosing dementia,
but in research single integer scores have typically been used following the original definitions
of the rating scales. Previous attempts of (semi-)automatic atrophy measures have output a
continuous measure [17, 18, 63, 19]. The main advantages of using a continuous measure of
atrophy are 1) atrophy evolves continuously and thus it is reasonable to describe its degree
through a continuous measure, and 2) it provides more detailed information about the severity
of the atrophy. The latter point is for instance particularly useful to track disease progression
and could allow us to establish more sensitive cut-off values for different diagnoses. It is also
easy to convert the continuous measures of the rating scales to their discrete, original versions
by rounding to nearest integer.
In Fig. 5 we show some examples between AVRA’s continuous and the radiologist discrete
ratings in the important diagnostic interval between MTA=2 and MTA=3. When studying
these images again post AVRA’s ratings, the radiologist only assessed that the images originally
rated MTA=2 with associated AVRA scores of 2.6-3.0 to be wrongly rated. They would be
re-rated as MTA=3, i.e. closer to AVRA’s score. The image scored MTA=2 (radiologist) and
MTA=2.4 (AVRA) was described as a case between 2 and 3, which may illustrate the usefulness
of continuous ratings. However, we noticed that in two of the most disagreeing ratings (L.C.:
MTA=3, Avra: MTA={2.0, 2.2}) the individuals had an adhesion between the hippocampus
and the cerebral white matter. These cases are not frequent, and the rating disagreements in Fig.
5 indicate that AVRA did not learn to correctly adjust the score for the presence of adhesions.
We aimed to design AVRA to function on images with the least amount of preprocessing
possible to demonstrate that it could work in a clinical setting. A few concessions were made to
facilitate the training process—mainly the AC-PC alignment performed through rigid registra-
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tion to the MNI brain using FSL FLIRT. This helped centering all images to allow for tighter
cropping around the structures of interest. However, this automatic preprocessing step failed in
around 2.5% of all images, which were discarded for future training and evaluation although the
quality of most of the images was good enough for a radiologist to visually rate it. Since the
MRI image input to CNN has not been intensity normalized, skull stripped or motion corrected,
it is possible to perform a manual AC-PC alignment for the failed cases and then input them
to the model. More extensive data augmentation and training, or using reinforcement learning
to find the correct slice, could potentially be used to avoid the AC-PC alignment step and just
input the raw MRI image. This was, however, not explored in the current study.
4.3. Limitations
There are some limitations of the proposed algorithm. First, the models are solely based on
the ratings by a single radiologist and thus assume that the ratings we trained the model on are
”ground truth” labels. A model trained on these labels can therefore never be ”better” than the
rater. If the ratings have systematic errors the model will incorporate these. For instance, a rater
might systematically look at the left medial temporal lobe when rating the MTA of the right
hemisphere, which could influence (bias) the right hemisphere MTA score. If we train a model
on these ratings, this bias would be learned by the model as well. Another approach would be to
have multiple expert radiologists rate a set of images together or separately and use these labels
as ground truth. However, it is not feasible to have multiple radiologist visually assess the large
number of images necessary for training a deep neural network. It also does not automatically
mean that these ratings would necessarily be ”closer” to the ground truth. If future studies want
to use a neural network based on their own set of ratings, it should be possible to start from the
pre-trained networks of AVRA and fine-tune the final classification layer(s) on the new ratings.
This would require substantially fewer ratings, since the convolutional part would already have
learned to extract relevant features from the images.
The second limitation of the study are the small numbers of the highest GCA-F and PA
ratings, which may increase the risk of ”true” 3 score to be misclassified. Based on the results
in Fig. 6 this seems to be the case. As the diagnostic cut-off values for these ratings scales in
AD diagnosis have been suggested as PA ≥1 and GCA-F≥1 [13], the clinical implications of this
may be minor even in the cases where the atrophy is rated as a 2 instead of a 3. These severe
ratings are rare also in previous studies on dementia cohorts [13, 64], so this will likely be an
issue for any computerized method trained on radiologist ratings.
5. Conclusion
In this study, we have proposed an automatic method (AVRA) to provide visual ratings of
atrophy according to Scheltens’ MTA scale, Koedam’s PA scale, and Pasquier’s frontal GCA
scale. AVRA mimics the neuroradiologist’s rating procedure and achieves similar levels of agree-
ment to that between two experienced neuroradiologists—without any prior preprocessing of the
MRI images. We plan to make AVRA freely available as a user-friendly software aimed towards
neuroscientists and neuroradiologists.
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